Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | FGFR1 positive |
Therapy | Infigratinib |
Indication/Tumor Type | synovial sarcoma |
Response Type | decreased response |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR1 positive | synovial sarcoma | decreased response | Infigratinib | Preclinical - Cell culture | Actionable | In a preclinical study, synovial sarcoma cells with moderate Fgfr1 expression level demonstrated decreased response to Truseltiq (infigratinib) in culture (PMID: 27535980). | 27535980 |
PubMed Id | Reference Title | Details |
---|---|---|
(27535980) | Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma. | Full reference... |